Cabaletta Bio Inc (NASDAQ: CABA) is -24.85% lower on its value in year-to-date trading and has touched a low of $6.94 and a high of $26.35 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CABA stock was last observed hovering at around $17.15 in the last trading session, with the day’s loss setting it -0.09%.
Currently trading at $17.06, the stock is -14.01% and -20.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.78 million and changing -0.52% at the moment leaves the stock 0.63% off its SMA200. CABA registered 126.26% gain for a year compared to 6-month gain of 16.05%. The firm has a 200-day simple moving average (SMA200) of -$8.01.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -25.99% loss in the last 1 month and extending the period to 3 months gives it a -26.97%, and is -2.74% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.56% over the week and 7.24% over the month.
Cabaletta Bio Inc (CABA) has around 103 employees, a market worth around $731.02M and $0.00M in sales. Distance from 52-week low is 145.82% and -35.26% from its 52-week high. The company has generated returns on investments over the last 12 months (-28.48%).
Cabaletta Bio Inc quarterly earnings per share for the current quarter are estimated at -$0.48.The EPS is expected to shrink by -14.64% this year.
Cabaletta Bio Inc (CABA) Top Institutional Holders
188 institutions hold shares in Cabaletta Bio Inc (CABA), with institutional investors hold 104.83% of the company’s shares. The shares outstanding are 47.82M, and float is at 33.75M with Short Float at 21.01%. Institutions hold 101.54% of the Float.
The top institutional shareholder in the company is Fred Alger Management, LLC with over 4.57 million shares valued at $59.04 million. The investor’s holdings represent 11.49% of the CABA Shares outstanding. As of Jun 29, 2023, the second largest holder is Adage Capital Partners GP L.L.C. with 3.27 million shares valued at $42.17 million to account for 8.21% of the shares outstanding. The other top investors are Commodore Capital Lp which holds 2.37 million shares representing 5.95% and valued at over $30.57 million, while Deerfield Management Company, L.P. (Series C) holds 5.88% of the shares totaling 2.34 million with a market value of $30.21 million.
Cabaletta Bio Inc (CABA) Insider Activity
The most recent transaction is an insider sale by Binder Gwendolyn. SEC filings show that Binder Gwendolyn sold 11,000 shares of the company’s common stock on Jan 19 ’24 at a price of $19.59 per share for a total of $0.22 million. Following the sale, the insider now owns 20000.0 shares.
Cabaletta Bio Inc disclosed in a document filed with the SEC on Dec 19 ’23 that Binder Gwendolynsold a total of 11,000 shares of the company’s common stock. The trade occurred on Dec 19 ’23 and was made at $21.89 per share for $0.24 million. Following the transaction, the insider now directly holds 20000.0 shares of the CABA stock.
Still, SEC filings show that on Nov 20 ’23, Binder Gwendolyn () disposed off 11,000 shares at an average price of $17.82 for $0.2 million. The insider now directly holds 20,000 shares of Cabaletta Bio Inc (CABA).
